John E. Landers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John E. Landers has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Nicola Ticozzi
Department of Neurology and Laboratory of Neuroscience IRCCS Istituto Auxologico Italiano Milan Italy
19 shared publications - Vincenzo Silani
Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
15 shared publications - Jan Herman Veldink
Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
10 shared publications - Karen E. Morrison
School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK
10 shared publications - Russell Lewis McLaughlin
Smurfit Institute of Genetics, Trinity College Dublin
10 shared publications - Ammar Al-Chalabi
King's College London
9 shared publications
Latest Publications
- 1 September 2026
- Published by Institute of Mathematical Statistics in The Annals of Applied Statistics
- Vol. 20 (3) , 2074-2097
Integrated weighted association test with application to genetic association studies
The integrative association test utilizes a weighting scheme to combine prior information and increase statistical power. In whole-genome sequencing (WGS) studies, it facilitates the integration of biological characteristics of single nucleotide variants (SNVs) to improve the detection of novel disease genes. Despite recent applied advances, determining the best weights to fully leverage relevant information remains an open question. For a broad family of weighted integrative tests, this paper proposes optimized weights that maximize the tests’ asymptotic efficiency, a dominant metric influencing statistical power. The study elucidates how weighting enhances statistical power and designs a practical approach for integrating effective information from SNV allele frequencies, annotations, and linkage disequilibrium. Extensive simulations demonstrate improved statistical power compared to existing methods. An osteoporosis case study further illustrates the method’s application and potential for detecting additional novel disease genes.
- 1 September 2026
- Published by Institute of Mathematical Statistics in The Annals of Applied Statistics
- Vol. 20 (3) , 2074-2097
Integrated weighted association test with application to genetic association studies
The integrative association test utilizes a weighting scheme to combine prior information and increase statistical power. In whole-genome sequencing (WGS) studies, it facilitates the integration of biological characteristics of single nucleotide variants (SNVs) to improve the detection of novel disease genes. Despite recent applied advances, determining the best weights to fully leverage relevant information remains an open question. For a broad family of weighted integrative tests, this paper proposes optimized weights that maximize the tests’ asymptotic efficiency, a dominant metric influencing statistical power. The study elucidates how weighting enhances statistical power and designs a practical approach for integrating effective information from SNV allele frequencies, annotations, and linkage disequilibrium. Extensive simulations demonstrate improved statistical power compared to existing methods. An osteoporosis case study further illustrates the method’s application and potential for detecting additional novel disease genes.
- Open Access
Global transcriptional changes across multiple isogenic C9orf72 patient iPSC-derived neurons
- Top Cited PapersOpen Access
- 31 March 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (4) , 717-725
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a heritable disorder where rare variants with low-to-moderate penetrance are thought to dominate genetic risk. To identify such rare variants, we harmonized and analyzed exome data from 22 cohorts, totaling 17,919 individuals with ALS and 200,703 controls across discovery and replication phases. Rare variant analyses identified several new risk genes, with replication confirming association of YKT6 and supporting HTR3C , GBGT1 and KNTC1 . We also provide strong, independent validation for genes with limited previous evidence: ARPP21 , DNAJC7 and CFAP410 . Notably, in ARPP21 , we identified a new high-effect variant (p.P747L) and confirmed that p.P563L is an ALS-associated variant leading to an aggressive disease course. Beyond new discoveries, our analyses largely recapitulated the known genetic architecture of ALS, identifying risk variants in over 20% of cases and supporting a cumulative oligogenic risk model. These findings highlight new translational targets and show that rare variant analyses capture substantially more genetic risk than common variant genome-wide association studies.
- 31 March 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (4) , 717-725
Top Cited PapersOpen AccessLarge-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a heritable disorder where rare variants with low-to-moderate penetrance are thought to dominate genetic risk. To identify such rare variants, we harmonized and analyzed exome data from 22 cohorts, totaling 17,919 individuals with ALS and 200,703 controls across discovery and replication phases. Rare variant analyses identified several new risk genes, with replication confirming association of YKT6 and supporting HTR3C , GBGT1 and KNTC1 . We also provide strong, independent validation for genes with limited previous evidence: ARPP21 , DNAJC7 and CFAP410 . Notably, in ARPP21 , we identified a new high-effect variant (p.P747L) and confirmed that p.P563L is an ALS-associated variant leading to an aggressive disease course. Beyond new discoveries, our analyses largely recapitulated the known genetic architecture of ALS, identifying risk variants in over 20% of cases and supporting a cumulative oligogenic risk model. These findings highlight new translational targets and show that rare variant analyses capture substantially more genetic risk than common variant genome-wide association studies.
- Open Access
- 2 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-2
Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
- 2 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-2
Open AccessAuthor Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
- Open Access
- 10 June 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56 (7) , 1371-1376
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Despite substantial progress, causal variants are identified only for a minority of familial Parkinson’s disease (PD) cases, leaving high-risk pathogenic variants unidentified1,2. To identify such variants, we uniformly processed exome sequencing data of 2,184 index familial PD cases and 69,775 controls. Exome-wide analyses converged on RAB32 as a novel PD gene identifying c.213C > G/p.S71R as a high-risk variant presenting in ~0.7% of familial PD cases while observed in only 0.004% of controls (odds ratio of 65.5). This variant was confirmed in all cases via Sanger sequencing and segregated with PD in three families. RAB32 encodes a small GTPase known to interact with LRRK2 (refs. 3,4). Functional analyses showed that RAB32 S71R increases LRRK2 kinase activity, as indicated by increased autophosphorylation of LRRK2 S1292. Here our results implicate mutant RAB32 in a key pathological mechanism in PD—LRRK2 kinase activity5–7—and thus provide novel insights into the mechanistic connections between RAB family biology, LRRK2 and PD risk.
- 10 June 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56 (7) , 1371-1376
Open AccessSystematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Despite substantial progress, causal variants are identified only for a minority of familial Parkinson’s disease (PD) cases, leaving high-risk pathogenic variants unidentified1,2. To identify such variants, we uniformly processed exome sequencing data of 2,184 index familial PD cases and 69,775 controls. Exome-wide analyses converged on RAB32 as a novel PD gene identifying c.213C > G/p.S71R as a high-risk variant presenting in ~0.7% of familial PD cases while observed in only 0.004% of controls (odds ratio of 65.5). This variant was confirmed in all cases via Sanger sequencing and segregated with PD in three families. RAB32 encodes a small GTPase known to interact with LRRK2 (refs. 3,4). Functional analyses showed that RAB32 S71R increases LRRK2 kinase activity, as indicated by increased autophosphorylation of LRRK2 S1292. Here our results implicate mutant RAB32 in a key pathological mechanism in PD—LRRK2 kinase activity5–7—and thus provide novel insights into the mechanistic connections between RAB family biology, LRRK2 and PD risk.
- Open Access
- 20 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-25
Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia
Microglia play a pivotal role in neurodegenerative disease pathogenesis, but the mechanisms underlying microglia dysfunction and toxicity remain to be elucidated. To investigate the effect of neurodegenerative disease-linked genes on the intrinsic properties of microglia, we studied microglia-like cells derived from human induced pluripotent stem cells (iPSCs), termed iMGs, harboring mutations in profilin-1 (PFN1) that are causative for amyotrophic lateral sclerosis (ALS). ALS-PFN1 iMGs exhibited evidence of lipid dysmetabolism, autophagy dysregulation and deficient phagocytosis, a canonical microglia function. Mutant PFN1 also displayed enhanced binding affinity for PI3P, a critical signaling molecule involved in autophagic and endocytic processing. Our cumulative data implicate a gain-of-toxic function for mutant PFN1 within the autophagic and endo-lysosomal pathways, as administration of rapamycin rescued phagocytic dysfunction in ALS-PFN1 iMGs. These outcomes demonstrate the utility of iMGs for neurodegenerative disease research and implicate microglial vesicular degradation pathways in the pathogenesis of these disorders.
- 20 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-25
Open AccessExpression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia
Microglia play a pivotal role in neurodegenerative disease pathogenesis, but the mechanisms underlying microglia dysfunction and toxicity remain to be elucidated. To investigate the effect of neurodegenerative disease-linked genes on the intrinsic properties of microglia, we studied microglia-like cells derived from human induced pluripotent stem cells (iPSCs), termed iMGs, harboring mutations in profilin-1 (PFN1) that are causative for amyotrophic lateral sclerosis (ALS). ALS-PFN1 iMGs exhibited evidence of lipid dysmetabolism, autophagy dysregulation and deficient phagocytosis, a canonical microglia function. Mutant PFN1 also displayed enhanced binding affinity for PI3P, a critical signaling molecule involved in autophagic and endocytic processing. Our cumulative data implicate a gain-of-toxic function for mutant PFN1 within the autophagic and endo-lysosomal pathways, as administration of rapamycin rescued phagocytic dysfunction in ALS-PFN1 iMGs. These outcomes demonstrate the utility of iMGs for neurodegenerative disease research and implicate microglial vesicular degradation pathways in the pathogenesis of these disorders.
- Open Access
- 18 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (33) , eadi5548
Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import
Loss-of-function variants in NIMA-related kinase 1 (NEK1) constitute a major genetic cause of amyotrophic lateral sclerosis (ALS), accounting for 2 to 3% of all cases. However, how NEK1 mutations cause motor neuron (MN) dysfunction is unknown. Using mass spectrometry analyses for NEK1 interactors and NEK1-dependent expression changes, we find functional enrichment for proteins involved in the microtubule cytoskeleton and nucleocytoplasmic transport. We show that α-tubulin and importin-β1, two key proteins involved in these processes, are phosphorylated by NEK1 in vitro. NEK1 is essential for motor control and survival in Drosophila models in vivo, while using several induced pluripotent stem cell (iPSC)–MN models, including NEK1 knockdown, kinase inhibition, and a patient mutation, we find evidence for disruptions in microtubule homeostasis and nuclear import. Notably, stabilizing microtubules with two distinct classes of drugs restored NEK1-dependent deficits in both pathways. The capacity of NEK1 to modulate these processes that are critically involved in ALS pathophysiology renders this kinase a formidable therapeutic candidate.
- 18 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (33) , eadi5548
Open AccessLoss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import
Loss-of-function variants in NIMA-related kinase 1 (NEK1) constitute a major genetic cause of amyotrophic lateral sclerosis (ALS), accounting for 2 to 3% of all cases. However, how NEK1 mutations cause motor neuron (MN) dysfunction is unknown. Using mass spectrometry analyses for NEK1 interactors and NEK1-dependent expression changes, we find functional enrichment for proteins involved in the microtubule cytoskeleton and nucleocytoplasmic transport. We show that α-tubulin and importin-β1, two key proteins involved in these processes, are phosphorylated by NEK1 in vitro. NEK1 is essential for motor control and survival in Drosophila models in vivo, while using several induced pluripotent stem cell (iPSC)–MN models, including NEK1 knockdown, kinase inhibition, and a patient mutation, we find evidence for disruptions in microtubule homeostasis and nuclear import. Notably, stabilizing microtubules with two distinct classes of drugs restored NEK1-dependent deficits in both pathways. The capacity of NEK1 to modulate these processes that are critically involved in ALS pathophysiology renders this kinase a formidable therapeutic candidate.
- Open Access
- 12 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
Superoxide dismutase (SOD1) gene variants may cause amyotrophic lateral sclerosis, some of which are associated with a distinct phenotype. Most studies assess limited variants or sample sizes. In this international, retrospective observational study, we compare phenotypic and demographic characteristics between people with SOD1-ALS and people with ALS and no recorded SOD1 variant. We investigate which variants are associated with age at symptom onset and time from onset to death or censoring using Cox proportional-hazards regression. The SOD1-ALS dataset reports age of onset for 1122 and disease duration for 883 people; the comparator population includes 10,214 and 9010 people respectively. Eight variants are associated with younger age of onset and distinct survival trajectories; a further eight associated with younger onset only and one with distinct survival only. Here we show that onset and survival are decoupled in SOD1-ALS. Future research should characterise rarer variants and molecular mechanisms causing the observed variability.
- 12 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Open AccessThe SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
Superoxide dismutase (SOD1) gene variants may cause amyotrophic lateral sclerosis, some of which are associated with a distinct phenotype. Most studies assess limited variants or sample sizes. In this international, retrospective observational study, we compare phenotypic and demographic characteristics between people with SOD1-ALS and people with ALS and no recorded SOD1 variant. We investigate which variants are associated with age at symptom onset and time from onset to death or censoring using Cox proportional-hazards regression. The SOD1-ALS dataset reports age of onset for 1122 and disease duration for 883 people; the comparator population includes 10,214 and 9010 people respectively. Eight variants are associated with younger age of onset and distinct survival trajectories; a further eight associated with younger onset only and one with distinct survival only. Here we show that onset and survival are decoupled in SOD1-ALS. Future research should characterise rarer variants and molecular mechanisms causing the observed variability.
- Open Access
- 5 April 2022
- Published by Elsevier in Cell Reports
- Vol. 39 (1) , 110598
ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function
- 5 April 2022
- Published by Elsevier in Cell Reports
- Vol. 39 (1) , 110598
Open AccessALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function
- 23 February 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (633) , eabj0264
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an estimated heritability between 40 and 50%. DNA methylation patterns can serve as proxies of (past) exposures and disease progression, as well as providing a potential mechanism that mediates genetic or environmental risk. Here, we present a blood-based epigenome-wide association study meta-analysis in 9706 samples passing stringent quality control (6763 patients, 2943 controls). We identified a total of 45 differentially methylated positions (DMPs) annotated to 42 genes, which are enriched for pathways and traits related to metabolism, cholesterol biosynthesis, and immunity. We then tested 39 DNA methylation–based proxies of putative ALS risk factors and found that high-density lipoprotein cholesterol, body mass index, white blood cell proportions, and alcohol intake were independently associated with ALS. Integration of these results with our latest genome-wide association study showed that cholesterol biosynthesis was potentially causally related to ALS. Last, DNA methylation at several DMPs and blood cell proportion estimates derived from DNA methylation data were associated with survival rate in patients, suggesting that they might represent indicators of underlying disease processes potentially amenable to therapeutic interventions.
- 23 February 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (633) , eabj0264
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an estimated heritability between 40 and 50%. DNA methylation patterns can serve as proxies of (past) exposures and disease progression, as well as providing a potential mechanism that mediates genetic or environmental risk. Here, we present a blood-based epigenome-wide association study meta-analysis in 9706 samples passing stringent quality control (6763 patients, 2943 controls). We identified a total of 45 differentially methylated positions (DMPs) annotated to 42 genes, which are enriched for pathways and traits related to metabolism, cholesterol biosynthesis, and immunity. We then tested 39 DNA methylation–based proxies of putative ALS risk factors and found that high-density lipoprotein cholesterol, body mass index, white blood cell proportions, and alcohol intake were independently associated with ALS. Integration of these results with our latest genome-wide association study showed that cholesterol biosynthesis was potentially causally related to ALS. Last, DNA methylation at several DMPs and blood cell proportion estimates derived from DNA methylation data were associated with survival rate in patients, suggesting that they might represent indicators of underlying disease processes potentially amenable to therapeutic interventions.